Subscribe
shutterstock_384310168_doro_guzenda
Doro Guzenda / Shutterstock.com
19 April 2022MedtechFran Salisbury and Alice Jefferies

Predicting the unpredictable during pregnancy

A pressing need for more non-invasive prenatal tests is leading to increasing IP activity and commercial interest, say Fran Salisbury and Alice Jefferies of Mewburn Ellis.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
English High Court upholds Sequenom patent for prenatal test
18 June 2019   US-based gene sequencing company Sequenom was handed a win yesterday after a UK court ruled that The Doctors Laboratory and Ariosa Diagnostics, which is owned by Roche, had infringed its patent.
Americas
Illumina handed $27m in prenatal patent win
26 January 2018   A California jury has ordered Roche-owned Ariosa Diagnostics to pay US-based gene sequencing company Illumina $27 million in a patent dispute.


Editor's picks

UKIPO rejects Boehringer’s SPC for horse inhaler
Americas
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

Editor's picks

Americas
UKIPO rejects Boehringer’s SPC for horse inhaler
8 July 2025

More on this story

Big Pharma
English High Court upholds Sequenom patent for prenatal test
18 June 2019   US-based gene sequencing company Sequenom was handed a win yesterday after a UK court ruled that The Doctors Laboratory and Ariosa Diagnostics, which is owned by Roche, had infringed its patent.
Americas
Illumina handed $27m in prenatal patent win
26 January 2018   A California jury has ordered Roche-owned Ariosa Diagnostics to pay US-based gene sequencing company Illumina $27 million in a patent dispute.

More on this story

Big Pharma
English High Court upholds Sequenom patent for prenatal test
18 June 2019   US-based gene sequencing company Sequenom was handed a win yesterday after a UK court ruled that The Doctors Laboratory and Ariosa Diagnostics, which is owned by Roche, had infringed its patent.
Americas
Illumina handed $27m in prenatal patent win
26 January 2018   A California jury has ordered Roche-owned Ariosa Diagnostics to pay US-based gene sequencing company Illumina $27 million in a patent dispute.

More features

Startup challenges rival over brain monitoring tech at ITC
WilmerHale gains partner with ‘deep expertise’
Diverging in the detail: UPC local divisions and Court of Appeal take different paths
Three reasons why the UK should reconsider joining the UPC
FisherBroyles appoints biotech-focused partner in DC
Ukraine law change means rightsholders need to prepare
PierFerd hires partner with medtech expertise
Life sciences leaders recognised at LSPN Awards USA 2025